• Aucun résultat trouvé

[PDF] Top 20 Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.

Has 10000 "Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction." found on our website. Below are the top 20 most common "Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.".

Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.

Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.

... improvements in management, patients with heart failure with reduced ejection frac- tion (HFrEF) have reduced life expectancy, frequent heart ... Voir le document complet

14

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

... (MRA) therapy has been shown in ran- domized trials to reduce mortality in patients with heart failure and reduced ejection frac- tion (HFrEF), MRA ... Voir le document complet

12

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload

... the patients with or without recent volume overload were similar with respect to ejection fraction and eGFR, but pa- tients with recent volume overload were more likely to have a ... Voir le document complet

13

Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction

Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction

... of patients with stable heart failure also use loop diuretics chronically [ 1 – 4 ...]. Heart failure guidelines recom- mend to use loop diuretics to reduce the signs and ... Voir le document complet

13

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

... HAL Id: hal-02863402 https://hal.univ-lorraine.fr/hal-02863402 Submitted on 10 Jun 2020 HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they ... Voir le document complet

25

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

... Introduction Besides the risk for mortality and recurrent hospitalizations, patients with heart failure with reduced ejection fraction HFrEF also suffer from impaired health status.1,2 I[r] ... Voir le document complet

11

Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial

Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial

... of patients less prone to develop hyperkalaemia and the proto- col included recommendations to manage hyperkalaemia, both of which may have reduced the impact of hyperkalaemia relative to hypokalaemia ... Voir le document complet

10

Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure.

Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure.

... changes in echocardiographic parame- ters during exercise are listed in Table 2 ...greater with CRT on. During testing, heart rate increases from at rest to peak exercise were not affected by ... Voir le document complet

4

Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction

Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction

... examination in patients with acute heart failure: ...Echocardiography in Patients With Heart ...Ultrasound in Ambulatory Patients With ... Voir le document complet

30

The continuous heart failure spectrum: moving beyond an ejection fraction classification

The continuous heart failure spectrum: moving beyond an ejection fraction classification

... used heart failure (HF) patients with low left ventricular ejection fraction (LVEF) to select study pop- ulations with high risk to enhance statistical ...LVEF in ... Voir le document complet

12

Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

... study in a stable heart failure population with a history of myocardial infarction ( ...function in tandem with measures of global clinical ...chronic heart failure ... Voir le document complet

10

Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach

Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach

... HFpEF patients, the coronary microvascular endothelial expression of adhesion molecules, such as E-selectin, intercellular adhesion molecule (ICAM), and vascular cell adhesion molecule (VCAM), is ...molecules ... Voir le document complet

20

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score

... used in isolation for stratifying risk in an individual patient with ...trials in HFpEF identi fied many echocardiographic variables that might provide additional prognostic insights and ... Voir le document complet

14

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

... all patients provided written informed ...Study Patients Participants included patients ≥18 years or older who had chronic heart failure (New York Heart Association (NYHA) ... Voir le document complet

35

A personalized algorithm-based discharge checklist in patients with acute heart failure

A personalized algorithm-based discharge checklist in patients with acute heart failure

... effective in patients with heart failure with preserved ejection fraction ...findings in patients with heart failure, including ... Voir le document complet

29

Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction

Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction

... and patients with decompensated HF exhibit a 40% increase in PV compared with healthy controls 9 ...associated with clinical outcomes in patients with acute HF and ... Voir le document complet

28

Tumour biomarkers: association with heart failure outcomes.

Tumour biomarkers: association with heart failure outcomes.

... of patients were males, and less statistical power and independent determi- nants were available to make statements about ...on patients with decompensated HF with reduced ... Voir le document complet

13

Circulating neuregulin1-beta in heart failure with preserved and reduced left ventricular ejection fraction

Circulating neuregulin1-beta in heart failure with preserved and reduced left ventricular ejection fraction

... quantified in 86 stable patients with HFpEF (EF ≥45% and N-terminal pro-brain natriuretic peptide >300 ng/L), in 86 patients with HFrEF prior to and after left ventricular ... Voir le document complet

12

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction

... of heart failure with preserved ejection fraction The four descriptive models of HFpEF were used for which the FC-HF was required for all (Figure ...1). In addition, in ... Voir le document complet

11

Calcium dynamics and related alterations in pulmonary hypertension associated with heart failure

Calcium dynamics and related alterations in pulmonary hypertension associated with heart failure

... left heart filling pressure to pulmonary veins is in turn transferred to pulmonary ...clearance with eventual physical disruption of the alveolar-capillary barrier; a phenomenon termed capillary ... Voir le document complet

217

Show all 10000 documents...